Lab-Grown brain cells could unlock personalized OCD treatments

NCT ID NCT07488663

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at 60 people with obsessive-compulsive disorder (OCD) who either respond well to medication, respond to brain stimulation, or don't respond to either. Researchers will take blood samples and turn them into nerve cells in the lab to study how these cells react to treatments. The goal is to find biological markers that predict which therapy will work best for each person, paving the way for personalized OCD care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
deep transcranial magnetic stimulation (dTMS)
What this could lead to
If successful, this could lead to a lab test that predicts which OCD treatment will work best for each person, making therapy more personalized and effective.
What could go wrong
This is an early-stage, observational study with only 60 participants. The lab findings may not translate into real-world benefits, and the stem cell models may not fully capture the complexity of OCD.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBSESSIVE-COMPULSIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Asst Fatebenefratelli Sacco

    Milan, 20100, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.